Lars-Ivo Partecke
-
- Plasma Applications and Diagnostics 10
- Surfaces, Coatings and Films top 10%
-
- Immune cells in cancer 6
- Phagocytosis and Immune Regulation 3
-
- Pancreatic and Hepatic Oncology Research 5
-
- Nanoplatforms for cancer theranostics 7
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 2
-
- Heme Oxygenase-1 and Carbon Monoxide 2
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Sander BekeschusEric FreundKim Rouven LiedtkeClaus-Dieter HeideckeJulia van der LindeChristine HackbarthThomas von WoedtkeAndré Käding
- Partner nations
- GermanyNetherlandsBelgium
In The Last Decade
Lars-Ivo Partecke
21 papers receiving 806 citations
Peers
Comparison fields: 5 of 85
- Radiology, Nuclear Medicine and Imaging 379
- Surfaces, Coatings and Films 62
- Immunology 155
- Oncology 180
- Surgery 179
Countries citing papers authored by Lars-Ivo Partecke
This map shows the geographic impact of Lars-Ivo Partecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars-Ivo Partecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars-Ivo Partecke more than expected).
Fields of papers citing papers by Lars-Ivo Partecke
This network shows the impact of papers produced by Lars-Ivo Partecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars-Ivo Partecke. The network helps show where Lars-Ivo Partecke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars-Ivo Partecke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 42 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 31 | |
| 5 | 2020 | 18 | |
| 6 | 2020 | 14 | |
| 7 | 2019 | 38 | |
| 8 | 2019 | 127 | |
| 9 | 2019 | 41 | |
| 10 | 2019 | 30 | |
| 11 | 2018 | 40 | |
| 12 | 2018 | 184 | |
| 13 | 2018 | 28 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 16 | |
| 16 | 2017 | 38 | |
| 17 | 2013 | 42 | |
| 18 | 2013 | 45 | |
| 19 | 2012 | 3 | |
| 20 | 2010 | 36 |
About Lars-Ivo Partecke
Lars-Ivo Partecke is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Genetics, Oncology and Biomedical Engineering, having authored 21 papers that have together received 813 indexed citations. Recurring topics across this work include Plasma Applications and Diagnostics (10 papers), Nanoplatforms for cancer theranostics (7 papers), Immune cells in cancer (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Phagocytosis and Immune Regulation (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (379 citations), Surfaces, Coatings and Films (62 citations), Immunology (155 citations), Oncology (180 citations) and Surgery (179 citations). Lars-Ivo Partecke has collaborated with scholars based in Germany, Netherlands and Belgium. Frequent co-authors include Sander Bekeschus, Eric Freund, Kim Rouven Liedtke, Claus-Dieter Heidecke, Julia van der Linde, Christine Hackbarth, Thomas von Woedtke, André Käding, Hans‐Robert Metelmann and Matthias Sendler. Their work appears in journals such as Cancers, Pancreatology, Scientific Reports, Anti-Cancer Agents in Medicinal Chemistry and IEEE Transactions on Radiation and Plasma Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.